Biomarin Pharmaceutical B1MR34 Income Statements

Conto economico

Quarter End	Giu 2022	Set 2022	Dic 2022	Mar 2023	Giu 2023	Set 2023	Dic 2023	Mar 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Entrate totali	533,8M	505,34M	537,54M	596,42M	595,28M	581,33M	646,21M	648,83M
Reddito operativo	39,15M	-36,52M	-24,5M	59,35M	58,87M	25,66M	41,92M	78,46M
Reddito ante imposte	34,85M	-1,9M	-17,56M	56,76M	70,81M	41,67M	19,33M	105,55M
Reddito netto	27,66M	-6,65M	-249k	50,85M	56,04M	40,38M	20,38M	88,66M
Dividendi preferiti	0	0	0	0	0	0	0	0
Utile base per azione (EPS)	0	0	0	0	0	0	0	0
UTILE OPERATIVO	36,21M	71,67M	-22,64M	48,52M	61,95M	29,71M	35,08M	89,73M
EBITDA	62,45M	-11,72M	53k	85,77M	84,29M	51,35M	68,78M	105,81M

Fine anno 31 Dicembre 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Entrate totali	1,17B	1,31B	1,49B	1,7B	1,86B	1,85B	2,1B	2,42B
Reddito operativo	-803,97M	-135,19M	-174,08M	-126,04M	-96,27M	-20,41M	41,56M	185,8M
Reddito ante imposte	-831,05M	-35,88M	-142,71M	-94,81M	-42,32M	-13,42M	149,58M	188,56M
Reddito netto	-630,21M	-117,04M	-77,21M	-23,85M	859,1M	-2,15M	141,56M	167,65M
Dividendi preferiti	0	0	0	0	0	0	0	0
Utile base per azione (EPS)	-3.65	-0.666	-0.433	-0.133	4.727	-0.012	0.76	0.89
UTILE OPERATIVO	-799,04M	-2,22M	-121,87M	-94,1M	-29,62M	-8,56M	147,51M	175,26M
EBITDA	-101,45M	-23,19M	-53,38M	16,76M	57,37M	87,63M	143,53M	290,18M